Skip to main content Accessibility help
  • Print publication year: 2014
  • Online publication date: August 2014

Chapter 1 - Epidemiology of women with epilepsy


1. Banerjee PN, Filippi D and Allen Hauser W. The descriptive epidemiology of epilepsy – a review. Epilepsy Res 2009; 85(1):31–45.
2. Christensen J, Vestergaard M, Pederson MG, et al. Incidence and prevalence of epilepsy in Denmark. Epilepsy Res 2007; 76(1):60–5.
3. Ngugi AK, Bottomley C, Kleinschmidt I, et al. Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia 2010; 51(5):883–90.
4. Forsgren L, Beghi E, Oun A, et al. The epidemiology of epilepsy in Europe – a systematic review. Eur J Neurol 2005; 12(4):245–53.
5. Tellez-Zenteno JF, Pondal-Sordo M, Matijevic S, et al. National and regional prevalence of self-reported epilepsy in Canada. Epilepsia 2004; 45(12):1623–9.
6. Kobau R, Zahran H, Thurman DJ, et al. Epilepsy surveillance among adults – 19 states, behavioral risk factor surveillance system, 2005. MMWR Surveill Summ 2008; 57(6):1–20.
7. Kotsopoulos IA, van Merode T, Kessels FG, et al. Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures. Epilepsia 2002; 43(11):1402–9.
8. Christensen J, Kieldsen MJ, Anderson H, et al. Gender differences in epilepsy. Epilepsia 2005; 46(6):956–60.
9. Ngugi AK, Kariuki SM, Bottomley C, et al. Incidence of epilepsy: a systematic review and meta-analysis. Neurology 2011; 77(10):1005–12.
10. Hauser WA, Annegers JF and Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935–1984. Epilepsia 1993; 34(3):453–68.
11. Hesdorffer DC, Logroscino G, Benn EK, et al. Estimating risk for developing epilepsy: a population-based study in Rochester, Minnesota. Neurology 2010; 76(1):23–7.
12. Tellez-Zenteno JF, Patten SB, Jette N, et al. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 2007; 48(12):2336–44.
13. Tellez-Zenteno JF, Matijevic S and Wiebe S. Somatic comorbidity of epilepsy in the general population in Canada. Epilepsia 2005; 46(12):1955–62.
14. Fuller-Thomson E and Brennenstuhl S. The association between depression and epilepsy in a nationally representative sample. Epilepsia 2009; 50(5):1051–8.
15. Hesdorffer DC, Hauser WA, Olafsson E, et al. Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol 2006; 59(1):35–41.
16. Kanner AM. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol Psychiatry 2003; 54(3):388–98.
17. Turner K, Piazzini A, Franza A, et al. Epilepsy and postpartum depression. Epilepsia 2009; 50:24–7.
18. Gaitatzis A, Carroll K, Majeed A, et al. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 2004; 45(12):1613–22.
19. Manni R and Terzaghi M. Comorbidity between epilepsy and sleep disorders. Epilepsy Res 2010; 90(3):171–7.
20. van Golde EGA, Gutter T and de Weerd AW. Sleep disturbances in people with epilepsy: prevalence, impact and treatment. Sleep Med Rev 2011; 15(6):357–68.
21. Khatami R, Zutter D, Siegel A, et al. Sleep-wake habits and disorders in a series of 100 adult epilepsy patients – a prospective study. Seizure 2006; 15(5):299–306.
22. de Weerd A, de Haas S, Otte A, et al. Subjective sleep disturbance in patients with partial epilepsy: a questionnaire-based study on prevalence and impact on quality of life. Epilepsia 2004; 45(11):1397–1404.
23. Winawer MR and Shinnar S. Genetic epidemiology of epilepsy or what do we tell families? Epilepsia 2005; 46(Suppl 10):24–30.
24. McHugh JC and Delanty N. Chapter 2 epidemiology and classification of epilepsy. Int Rev of Neurobiol 2008; 83:11–26.
25. Waaler PE, Blom BH, Skeidsvoll H, et al. Prevalence, classification, and severity of epilepsy in children in western Norway. Epilepsia 2000; 41(7):802–10.
26. Briellmann RS, Jackson GD, Mitchell LA, et al. Occurrence of hippocampal sclerosis: is one hemisphere or gender more vulnerable? Epilepsia 1999; 40(12):1816–20.
27. Janszky J. Medial temporal lobe epilepsy: gender differences. J Neurol Neurosurg Psychiatry 2004; 75(5):773–5.
28. Herzog AG. Catamenial epilepsy: definition, prevalence pathophysiology and treatment. Seizure 2008; 17(2):151–9.
29. Herzog AG, Harden CL, Liporace J, et al. Frequency of catamenial seizure exacerbation in women with localization-related epilepsy. Ann Neurol 2004; 56(3):431–4.
30. El-Khayat HA, Oliman NA, Tomoum HY, et al. Reproductive hormonal changes and catamenial pattern in adolescent females with epilepsy. Epilepsia 2008; 49(9):1619–26.
31. Quigg M, Smithson SD, Fowler KM, et al. Laterality and location influence catamenial seizure expression in women with partial epilepsy. Neurology 2009; 73(3):223–7.
32. Morrell MJ, Flynn KL, Done S, et al. Sexual dysfunction, sex steroid hormone abnormalities, and depression in women with epilepsy treated with antiepileptic drugs. Epilepsy Behav 2005; 6(3):360–5.
33. Herzog AG, Coleman AE, Jacobs AR, et al. Relationship of sexual dysfunction to epilepsy laterality and reproductive hormone levels in women. Epilepsy Behav 2003; 4(4):407–13.
34. Pack AM. Implications of hormonal and neuroendocrine changes associated with seizures and antiepileptic drugs: a clinical perspective. Epilepsia 2010; 51:150–53.
35. Svalheim S, Taubøll E, Bjørnenak T, et al. Do women with epilepsy have increased frequency of menstrual disturbances? Seizure 2003; 12(8):529–33.
36. Herzog AG and Friedman MN. Menstrual cycle interval and ovulation in women with localization-related epilepsy. Neurology 2001; 57(11):2133–5.
37. Herzog AG, Coleman AE, Jacobs AR, et al. Interictal EEG discharges, reproductive hormones, and menstrual disorders in epilepsy. Ann Neurol 2003; 54(5):625–37.
38. Hu X, Wang J, Dong W, et al. A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy. Epilepsy Res 2011; 97(1–2):73–82.
39. Lofgren E, Mikkonen K, Tolonen U, et al. Reproductive endocrine function in women with epilepsy: the role of epilepsy type and medication. Epilepsy Behav 2007; 10(1):77–83.
40. Morrell, MJ, Hayes FJ, Sluss PM, et al. Hyperandrogenism, ovulatory dysfunction, and polycystic ovary syndrome with valproate versus lamotrigine. Ann Neurol 2008; 64(2):200–211.
41. Herzog AG, Seibel MM, Schomer DL, et al. Reproductive endocrine disorders in men with partial seizures of temporal lobe origin. Arch Neurol 1986; 43(4):347–50.
42. Herzog AG, Seibel MM, Schomer DL, et al. Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Arch Neurol 1986; 43(4):341–6.
43. Wallace H, Shorvon S and Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2 052 922 and age-specific fertility rates of women with epilepsy. Lancet 1998; 352(9145):1970–73.
44. Sukumaran SC, Sarma PS and Thomas SV. Polytherapy increases the risk of infertility in women with epilepsy. Neurology 2010; 75(15):1351–5.
45. Pack AM. Infertility in women with epilepsy: what’s the risk and why? Neurology 2010; 75(15):1316–7.
46. Gopinath M, Sarma PS and Thomas SV. Gender-specific psychosocial outcome for women with epilepsy. Epilepsy Behav 2011; 20(1):44–7.
47. Pack AM, Davis AR, Kritzer J, et al. Antiepileptic drugs: are women aware of interactions with oral contraceptives and potential teratogenicity? Epilepsy Behav 2009; 14(4):640–4.
48. Pennell PB. Hormonal aspects of epilepsy. Neurol Clin 2009; 27(4):941–65.
49. Wang H, Bos JH and de Jong-van den Berg LT. Co-prescription of antiepileptic drugs and contraceptives. Contraception 2012; 85(1):28–31.
50. Shorvon SD, Tallis RC and Wallace HK. Antiepileptic drugs: coprescription of proconvulsant drugs and oral contraceptives: a national study of antiepileptic drug prescribing practice. J Neurol Neurosurg Psychiatry 2002; 72(1):114–5.
51. Vessey M, Painter R and Yeates D. Oral contraception and epilepsy: findings in a large cohort study. Contraception 2002; 66(2):77–9.
52. Harden CL, Pennell PB, Koppel BS, et al. Management issues for women with epilepsy–focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2009; 50(5):1247–55.
53. Kaaja E, Kaaja R and Hiilesmaa V. Major malformations in offspring of women with epilepsy. Neurology 2003; 60(4):575–9.
54. Morrow JI, Hunt SJ, Russell AJ, et al. Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2009; 80(5):506–11.
55. Winterbottom JB, Smyth RM, Jacoby A, et al. Preconception counselling for women with epilepsy to reduce adverse pregnancy outcome. Cochrane Database Syst Rev 2008; (3):CD006645.
56. Winterbottom J, Smyth R, Jacoby A, et al. The effectiveness of preconception counseling to reduce adverse pregnancy outcome in women with epilepsy: what’s the evidence? Epilepsy Behav 2009; 14(2):273–9.
57. Pittschieler S, Brezinka C, Jahn B, et al. Spontaneous abortion and the prophylactic effect of folic acid supplementation in epileptic women undergoing antiepileptic therapy. J Neurol 2008; 255(12):1926–31.
58. Tomson T, Battino D, French J, et al. Antiepileptic drug exposure and major congenital malformations: the role of pregnancy registries. Epilepsy Behav 2007; 11(3):277–82.
59. Artama M, Auvinen A, Raudaskoski T, et al. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 2005; 64(11):1874–8.
60. Meador K, Reynolds MW, Crean S, et al. Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Res 2008; 81(1):1–13.
61. Molgaard-Nielsen D and Hviid A. Newer-generation antiepileptic drugs and the risk of major birth defects. JAMA 2011; 305(19):1996–2002.
62. Meador KJ, Baker GA, Browning N, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009; 360(16):1597–605.
63. Nadebaum C, Anderson VA, Vajda F, et al. Language skills of school-aged children prenatally exposed to antiepileptic drugs. Neurology 2011; 76(8):719–26.
64. Borthen I, Eide MG, Veiby G, et al. Complications during pregnancy in women with epilepsy: population-based cohort study. BJOG: An International Journal of Obstetrics & Gynaecology 2009; 116(13):1736–42.
65. Borthen I, Eide MG, Daltveit AK, et al. Delivery outcome of women with epilepsy:a population-based cohort study. BJOG 2010; 117(12):1537–43.
66. Veiby G, Daltveit AK, Engelson BA, et al. Pregnancy, delivery, and outcome for the child in maternal epilepsy. Epilepsia 2009; 50(9):2130–39.
67. Harden CL, Pennell PB, Koppel BS, et al. Management issues for women with epilepsy – focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes. Epilepsia 2009; 50(5):1237–46.
68. Viinikainen K, Heinonen S, Eriksson K, et al. Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy. Epilepsia 2006; 47(1):186–92.
69. Seizure control and treatment in pregnancy: observations from the EURAP Epilepsy Pregnancy Registry. Neurology 2006; 66(3):354–60.
70. Vajda FJ, Hitchcock A, Graham J, et al. Seizure control in antiepileptic drug-treated pregnancy. Epilepsia 2008; 49(1):172–6.
71. Meador KJ, Baker GA, Browning N, et al. Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology 2010; 75(22):1954–60.
72. Erel T and Guralp O. Epilepsy and menopause. Arch Gynecol Obstet 2011; 284(3):749–55.
73. Harden CL, Pulver MC, Ravdin L, et al. The effect of menopause and perimenopause on the course of epilepsy. Epilepsia 1999; 40(10):1402–7.
74. Harden CL, Koppel BS, Herzog AG, et al. Seizure frequency is associated with age at menopause in women with epilepsy. Neurology 2003; 61(4):451–5.
75. Klein P, Serje A and Pezzullo JC. Premature ovarian failure in women with epilepsy. Epilepsia 2001; 42(12):1584–9.
76. Vestergaard P, Rejnmark L and Mosekilde L. Fracture risk associated with use of antiepileptic drugs. Epilepsia 2004; 45(11):1330–7.
77. Jette N, Lix LM, Metge CJ, et al. Association of antiepileptic drugs with nontraumatic fractures: a population-based analysis. Arch Neurol 2011; 68(1):107–12.
78. Pack AM, Morrell MJ, Randall A, et al. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Neurology 2008; 70(18):1586–93.
79. Davis AR, Pack AM, Kritzer J, et al. Reproductive history, sexual behavior and use of contraception in women with epilepsy. Contraception 2008; 77(6):405–9.
80. Kanner AM. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol Psychiatry 2003; 54:388–98.